Skip to main content

Day: April 26, 2021

uniQure Announces FDA Removes Clinical Hold on Hemophilia B Gene Therapy Program

LEXINGTON, Mass. and AMSTERDAM, The Netherlands, April 26, 2021 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, announced today that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on the Company’s hemophilia B gene therapy program after determining the Company satisfactorily addressed all issues identified by the FDA related to a single patient diagnosed with hepatocellular carcinoma (HCC) in the HOPE-B pivotal trial. “Patient safety is our top priority, and we are grateful to our advisors and the FDA for their help in resolving this clinical hold,” stated Ricardo Dolmetsch, Ph.D., president of research and development at uniQure. “Our comprehensive investigation showed that AMT-061 (etranacogene dezaparvovec)...

Continue reading

Fortuna and Roxgold Agree to Business Combination Creating a Low-Cost Intermediate Global Precious Metals Producer

Creating a low-cost platform for gold and silver production growth in the world’s fastest growing precious metals producing regions Anticipated annual gold equivalent1production profile of approximately 450,0001,2,7ounces AISC3of approximately US$9505per gold equivalent ounce with a declining cost profile Extensive brownfield and greenfield organic growth potential supported by a large base of Mineral Reserves and Mineral Resources in Latin America and West Africa Lower cost of capital and strong balance sheet to fund the construction of the Séguéla gold Project in Côte d’Ivoire, advance exploration of the Boussoura gold Project in Burkina Faso as well as other organic and external growth opportunitiesVANCOUVER, British Columbia, April 26, 2021 (GLOBE NEWSWIRE) — Fortuna Silver Mines Inc. (“Fortuna” or the “Company”) (NYSE: FSM)...

Continue reading

FLYHT Announces Resolution of Claim

CALGARY, Alberta, April 26, 2021 (GLOBE NEWSWIRE) — FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “FLYHT”) announced today that the Company has executed a settlement agreement and mutual release (in respect of any claims between the parties) in respect of the litigation between Thomas R. Schmutz (former CEO of FLYHT) and the Company, as first announced on June 30, 2020. The parties have agreed upon a final settlement whereby FLYHT will pay Mr. Schmutz $225,000 CAD and 250,000 common shares in FLYHT. All of the common shares issued pursuant to the settlement agreement are subject to a 4-month hold period. The settlement is conditional upon final approval for the issuance of the common shares by the TSX Venture Exchange. About FLYHT Aerospace Solutions Ltd. FLYHT provides airlines with Actionable Intelligence...

Continue reading

Ocwen Financial Schedules Conference Call – Preliminary First Quarter 2021 Results and Business Update

WEST PALM BEACH, Fla., April 26, 2021 (GLOBE NEWSWIRE) — Ocwen Financial Corporation (NYSE: OCN) (“Ocwen” or the “Company”), a leading non-bank mortgage servicer and originator, today announced that it will hold a conference call on Thursday, April 29, 2021 at 8:30 a.m. (ET) to review the Company’s preliminary first quarter 2021 operating results and provide a business update. All interested parties are welcome to participate. You can access the conference call by dialing (877) 407-0792 or (201) 689-8263 approximately 10 minutes prior to the call. Participants can also access the conference call through a live audio webcast available from the Shareholder Relations page at www.ocwen.com under Events and Presentations. An investor presentation will accompany the conference call and be available by visiting the Shareholder Relations...

Continue reading

Dorman Products, Inc. Reports First Quarter 2021 Results

Highlights:Net sales of $288.0 million, up 12% as compared to $257.7 million in Q1 2020. Diluted earnings per share (“EPS”) of $1.02 up 46% as compared to $0.70 in Q1 2020. Adjusted diluted EPS* of $1.04, up 58% as compared to $0.66 in Q1 2020. Dorman’s strong balance sheet and ample liquidity provide solid foundation for growth. For fiscal 2021, the Company expects net sales growth between 9%-12%, diluted EPS of between $4.32 and $4.52, and adjusted diluted EPS* of between $4.40 and $4.60.COLMAR, Pa., April 26, 2021 (GLOBE NEWSWIRE) — Dorman Products, Inc. (the “Company” or “Dorman”) (NASDAQ:DORM), a leading supplier in the automotive aftermarket industry, today announced its financial results for the first quarter ended March 27, 2021. First Quarter Financial ResultsThe Company reported first quarter 2021 net sales of $288.0...

Continue reading

Alm. Brand A/S: Result of Annual General Meeting

Company announcement no. 6/2021 Result of annual general meeting held on 26 April 2021 The annual general meeting of Alm. Brand A/S held today was conducted in accordance with the agenda and the complete proposals submitted by the Board of Directors. The Annual Report for 2020 was approved, and discharge was granted to the Board of Directors and the Management Board. Moreover, the shareholders adopted the resolution proposed by the Board of Directors that the profit for the year of DKK 616 million be appropriated to the effect that dividends of DKK 4.00 per share be paid. The shareholders also adopted the resolution proposed by the Board of Directors that a dividend of DKK 3.00 per share for the 2019 financial year be paid, resulting in a total dividend payout of DKK 7.00 per share. The resolution proposed by the Board of Directors that...

Continue reading

Alm. Brand A/S: Resultat af ordinær generalforsamling

Selskabsmeddelelse nr. 6/2021 Resultat af ordinær generalforsamling den 26. april 2021 Den dags dato afholdte ordinære generalforsamling i Alm. Brand A/S blev gennemført i overensstemmelse med den fremlagte dagsorden og de af bestyrelsen fremlagte fuldstændige forslag. Årsrapporten for 2020 blev godkendt, og der blev meddelt decharge til bestyrelse og direktion. Endvidere blev bestyrelsens forslag om at disponere årets overskud på 616 mio. kr. således, at der udbetales udbytte på 4,00 kr. pr. aktie vedtaget. Endvidere blev bestyrelsens forslag om, at der udbetales et overskud på 3,00 kr. pr. aktie for regnskabsåret 2019 vedtaget, hvorefter den samlede udbyttebetaling bliver 7,00 kr. pr. aktie. Bestyrelsens forslag om, at bestyrelsen i tiden indtil næste ordinære generalforsamling skal være bemyndiget til at lade selskabet erhverve egne...

Continue reading

Party City to Report First Quarter 2021 Financial Results on May 10, 2021

ELMSFORD, N.Y., April 26, 2021 (GLOBE NEWSWIRE) — Party City Holdco Inc. (NYSE:PRTY) today announced that its first quarter 2021 financial results will be released prior to market open on Monday, May 10, 2021. The Company will host a conference call at 8:00 a.m. Eastern Time on that day to discuss the detailed financial results. Investors and analysts interested in participating in the call are invited to dial 844-757-5731 (international callers please dial 412-542-4126) approximately 10 minutes prior to the start of the call. A live audio webcast of the conference call will be available online at investor.partycity.com. About Party City Party City Holdco Inc. is the leading party goods company by revenue in North America and, we believe, the largest vertically integrated supplier of decorated party goods globally by revenue. The...

Continue reading

Genomics Market Size 2021 | Is Projected to Reach USD 94.66 Billion by 2028, Exhibiting a CAGR of 19.4%

Pune, India, April 26, 2021 (GLOBE NEWSWIRE) — The global genomics market size is projected to reach USD 94.66 billion by 2028, exhibiting a CAGR of 19.4% during the forecast period. Fortune Business Insights™ shares this information in its report, titled “Genomics Market, 2021-2028”. As per the report, the value of the market stood at USD 23.12 billion in 2020 and USD 27.81 billion in 2021. One of the key factors promoting the significance of this field of biology is its potential to manage zoonotic diseases, such as rabies, bird flu, plague, and the evident coronavirus. These diseases are life-threatening and can cause huge burdens if not monitored carefully. According to the World Health Organization, in 2020, rabies accounted for nearly 55 000 deaths in Asia and Africa. Genomic sequencing to Showcase High Demand amid COVID-19...

Continue reading

Talenom Oyj:n liiketoimintakatsaus tammi­–maaliskuu 2021 (tilintarkastamaton): Erinomainen alku tilikaudelle,  liikevoitto 21,7 % ja liikevaihdon kasvu 17,0 %  – Kasvun edellytykset vahvistuivat

Talenom Oyj, pörssitiedote 26.4.2021 klo 13:30 Talenom Oyj:n liiketoimintakatsaus tammi­–maaliskuu 2021 (tilintarkastamaton): Erinomainen alku tilikaudelle, liikevoitto 21,7 % ja liikevaihdon kasvu 17,0 % – Kasvun edellytykset vahvistuivat Tämä tiedote on tiivistelmä Talenom Oyj:n liiketoimintakatsauksesta tammi–maaliskuulta 2021. Liiketoimintakatsaus on kokonaisuudessaan tämän pörssitiedotteen liitteenä pdf-tiedostona ja lisäksi saatavilla yhtiön verkkosivuilla osoitteessa http://www.talenom.fi/sijoittajat. Tammi–maaliskuun 2021 yhteenveto: Liikevaihto 20,3 (17,4) milj. euroa, kasvu 17,0 (17,4) %  Liikevoitto (EBIT) 4,4 (3,7) milj. euroa, 21,7 (21,4) % liikevaihdosta  Nettotulos 3,3 (2,8) milj. euroa  Osakekohtainen tulos 0,08 (0,07) euroa  Talenom nosti 15.4.2021 ohjeistustaan vuodelle 2021 liikevaihdon osalta. Vuoden 2021 liikevaihdon...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.